Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.400 | 19 | 1220707 | frameshift variant | G/- | delins |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 0 | |||||||||||
|
0.776 | 0.400 | 19 | 1220707 | frameshift variant | G/- | delins |
|
0.700 | 0 | ||||||||||||
|
0.807 | 0.080 | 19 | 1206957 | missense variant | G/A | snv |
|
Neoplasms | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||||||
|
1.000 | 0.040 | 19 | 1220630 | missense variant | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.882 | 0.160 | 19 | 1220488 | missense variant | G/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.827 | 0.120 | 19 | 1186317 | intron variant | G/C | snv | 0.16 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.200 | 19 | 1207169 | stop gained | C/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.807 | 0.080 | 19 | 1206957 | missense variant | G/A | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.120 | 19 | 1221320 | missense variant | C/A;G;T | snv | 2.9E-05; 1.2E-04 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | ||||||||||
|
0.807 | 0.080 | 19 | 1223124 | missense variant | T/C | snv |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.120 | 19 | 1223126 | missense variant | C/G;T | snv | 5.2E-03; 4.1E-06 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 19 | 1220674 | missense variant | T/C | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 0 | |||||||||||
|
0.807 | 0.080 | 19 | 1223124 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.120 | 19 | 1223126 | missense variant | C/G;T | snv | 5.2E-03; 4.1E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.120 | 19 | 1186317 | intron variant | G/C | snv | 0.16 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.160 | 19 | 1220627 | missense variant | G/A | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.080 | 19 | 1220503 | stop gained | G/A;T | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.080 | 19 | 1220605 | missense variant | G/A | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 0.080 | 19 | 1223164 | missense variant | C/A;T | snv | 4.1E-06; 1.7E-05 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
0.790 | 0.120 | 19 | 1223126 | missense variant | C/G;T | snv | 5.2E-03; 4.1E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
1.000 | 0.040 | 19 | 1226005 | 3 prime UTR variant | C/A;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.120 | 19 | 1186317 | intron variant | G/C | snv | 0.16 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.080 | 19 | 1223124 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.790 | 0.120 | 19 | 1223126 | missense variant | C/G;T | snv | 5.2E-03; 4.1E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.200 | 19 | 1209715 | intron variant | C/G | snv | 0.53 |
|
Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 |